IMVT - Immunovant, Inc.
26.71
-1.040 -3.894%
Share volume: 830,413
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.31%
PREVIOUS CLOSE
CHG
CHG%
$27.75
-1.04
-0.04%
Summary score
21%
Profitability
25%
Dept financing
4%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.1%
Return on assets
-6.9%
Return on sales
0%
Return on invested capital
76.8%
Total debt ratio
11.65%
Debt ratio change over timeo
0%
Current Ratio
8.58%
Quick Ratio
0%
Cash Position Ratio
8.37%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.1%
Return on assets
-6.9%
Return on sales
0%
Return on invested capital
76.8%
Total debt ratio
11.65%
Debt ratio change over timeo
0%
Current Ratio
8.58%
Quick Ratio
0%
Cash Position Ratio
8.37%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-10.1%
Return on assets
-6.9%
Return on sales
0%
Return on invested capital
76.8%
Total debt ratio
11.65%
Debt ratio change over time
0%
Current Ratio
8.58%
Quick Ratio
0%
Cash Position Ratio
8.37%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IMVT | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -10.1% | 10.1% | 8.41% | 8.15% |
| Return on assets | -6.9% | 3.51% | 4.49% | 5.68% |
| Return on sales | 0% | 42.92% | 41.52% | 44.56% |
| Return on invested capital | 76.8% | 8.3% | 7.72% | 8.04% |
| Profitability | 25% | 67% | 66% | 73% |
| Total debt ratio | 11.65% | 71.21% | 65.97% | 47.54% |
| Debt ratio change over time | 0% | 0% | 468.93% | 4.59% |
| Dept financing | 4% | 25% | 48% | 17% |
| Current Ratio | 8.58% | 2.5% | 3.36% | 2.23% |
| Quick Ratio | 0% | 2.22% | 3.27% | 2.03% |
| Cash Position Ratio | 8.37% | 0.66% | 2.72% | 1.02% |
| Liquididy | 50% | 38% | 34% | 25% |
| Short-term ratios | IMVT | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -10.1% | 18.55% | 5.91% | 10.89% |
| Return on assets | -6.9% | 3.95% | 1.67% | 6.48% |
| Return on sales | 0% | 41.32% | 19.35% | 48.92% |
| Return on invested capital | 76.8% | 10.38% | 6.58% | 10.14% |
| Profitability | 25% | 65% | 26% | 68% |
| Total debt ratio | 11.65% | 82.58% | 64.48% | 49.63% |
| Debt ratio change over time | 0% | 0% | 933.93% | 4.55% |
| Dept financing | 4% | 25% | 45% | 15% |
| Current Ratio | 8.58% | 2.5% | 3.36% | 2.23% |
| Quick Ratio | 0% | 2.22% | 3.27% | 2.03% |
| Cash Position Ratio | 8.37% | 0.66% | 2.72% | 1.02% |
| Liquididy | 50% | 26% | 43% | 25% |